The University of Pittsburghs Youth and Family Research Program is recruiting children ages 6 to 12 who have been diagnosed with ADHD. The children will participate in a treatment study that will measure the safety and effectiveness of a long-acting form of Ritalin.

"During the first three weeks, all children will begin on a low dose of methylphenidate (commonly known at Ritalin) while parents receive an 11-session course of parenting training," the Pittsburgh Post-Gazette reported. "Over the next six weeks, half of the children will be randomly assigned to receive risperidone & in addition to methylphenidate, and half will receive a placebo."

The study will last for months. For more information, e-mail Heidi Kipp at kipphl@upmc.edu

Labels: medications, research

Posted By: Aspen/CRC